EYECARE Euclid Announces ABB Optical Group as Licensed Manufacturer and Distributor of Euclid Ortho-K Lenses By Staff Wednesday, June 28, 2023 12:18 AM STERLING, Va.—Euclid Vision Corporation, a leader in advanced orthokeratology (Ortho-K) lenses and proactive myopia management initiatives, has named ABB Optical Group as a licensed manufacturer and distributor of the company’s Ortho-K lenses. ABB is a leading distributor of soft lenses in the U.S., supplying nearly two-thirds of eyecare professionals across the U.S. with optical products, services and business solutions. Given ABB’s reach, this new collaboration will provide greater access to Euclid’s clinically proven Ortho-K contact lenses to a much wider audience of ECPs. “The manufacturing and distribution arrangement capitalizes on the strengths of two leading companies in the specialty contact lens arena and manifests our shared vision of growing accessibility to myopia management products and services,” said Joseph Boorady, president and CEO, Euclid. Euclid is the manufacturer of the Euclid Emerald and Euclid MAX Ortho-K contact lenses, which are worn overnight and are designed to reshape the cornea, so patients wake up to clear vision. Euclid’s Ortho-K lenses have a unique design that yields an 87 percent first fit success without requiring a trial set. ABB is well-equipped to support the manufacturing of Euclid’s lenses with their decades of gas permeable (GP) and custom soft lens manufacturing and specialty vision products distribution expertise. Aaron See, senior vice president of manufacturer partnerships for ABB said, “We are excited to work with Euclid and expand our licensed manufacturing, distribution, and myopia management product offerings with the addition of Euclid MAX lenses, a next-generation Ortho-K product. Recognizing the continued rise of myopia as a serious eye health issue, we are proud to bring an innovative Ortho-K design, which has the highest Dk of any U.S. overnight Ortho-K brand, to our ABB customers.” Myopia is the leading cause of visual impairment in children worldwide, and its incidence and prevalence are on the rise, with estimates suggesting that more than half of the world’s population will be myopic by 2050. “Increased accessibility to Euclid’s Ortho-K lenses means ABB’s customers can broaden their myopia management initiatives and help more myopic children at a critical time in the myopia epidemic,” said Nitin Jain, chief commercialization officer, Euclid. “This trend presents both a clinical challenge and practice management opportunity for ECPs poised to best serve their myopic patients. Together with ABB, we can provide easier access to myopia management products to help mitigate the extent of this epidemic,” added Jain. Visit the Euclid MAX landing page for more information.